Key terms
About AMRN
Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest AMRN news
Yesterday
1:12pm ET
Amarin Shareholders Show Strong Support at Annual Meeting
Apr 08
8:31am ET
Amarin highlights key data on mechanistic insights into eicosapentaenoic acid
Apr 07
6:48am ET
Amarin presents new REDUCE-IT analyses at ACC.24
Apr 03
8:14am ET
Amarin extends Vazkepa commercial runway in Europe for eight more years
Mar 25
8:23am ET
Amarin to present research on benefits of VASCEPA/VAZKEPA
Mar 08
8:45am ET
Largest borrow rate increases among liquid names
Mar 05
8:45am ET
Largest borrow rate increases among liquid names
Mar 01
1:00am ET
Amarin Corporation Plc’s New Competition Risk – A Cause for Worry?
Feb 29
12:35pm ET
Amarin’s Sell Rating Affirmed Amid Declining U.S. Sales and Uncertain International Expansion
Feb 29
7:06am ET
Amarin reports Q4 EPS 0c, consensus (3c)
Feb 29
7:05am ET
Options Volatility and Implied Earnings Moves Today, February 29, 2024
Feb 20
8:45am ET
Largest borrow rate increases among liquid names
Feb 14
8:45am ET
Largest borrow rate increases among liquid names
Feb 02
8:45am ET
Largest borrow rate increases among liquid names
Jan 27
4:02am ET
Amarin Regains Compliance, Maintains NASDAQ Listing
No recent press releases are available for AMRN
AMRN Financials
Key terms
Ad Feedback
AMRN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
AMRN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
